If you would like to read the full article please go to the following link: ICT media (This article is extracted from International Clinical Trials May 2020, page 54-55. © Samedan Ltd)
Read moreUn trabajo con participación del CSIC descubre un mecanismo molecular que emplea esta bacteria para percibir su entorno y regular así su supervivencia y patogénesis
Read moreTekniker is currently optimising a device used to diagnose the risk of imminent preterm births in pregnant women who come to the emergency ward presenting labour systems before their scheduled date. T...
Read moreBarraquer attributes the increase in ocular pathologies such as dry eye, computer visual syndrome, conjunctivitis or increased myopia, to the high exposure to electronic devices during confinement.
Read moreIn the first months of 2020, positive results in gene therapy of X-linked retinitis pigmentosa (XLRP) have been reported. XLRP is an inherited genetic disorder that causes progressive vision loss, mai...
Read moreEstos días en los que la crisis del coronavirus afecta a nuestros hábitos,a nuestra rutina y a nuestras relaciones sociales y familiares es posible sentir ansiedad y estrés. La ansiedad no es una e...
Read moreLos primeros datos del estudio de seroprevalencia, ENE-COVID, revelan una baja inmunidad en la población. El informe muestra una prevalencia de anticuerpos en el 5 %, unos 2 millones de personas, muy...
Read moreReig Jofre, a CataloniaBio & HealthTech member, is the force behind a clinical study to evaluate the efficacy of the Manremyc® in 300 health professionals exposed to the risk of contracting Covid-...
Read moreA new study reveals that it is possible to identify those individuals that will be protected by the vaccine before its administration
Read moreAfonso Mateos, profesor de la ETSI Informáticos de la UPM y Eloy Vicente Cestero, doctor en Inteligencia Artificial y científico de datos de esta universidad analizan en este artículo el impacto de...
Read moreSOM Biotech reoriented its capabilities to search for the treatments of COVID-19. Raúl Insa, CEO of SOM Biotech, acknowledges that he had never thought of using his technology to find treatment fo...
Read more